Accesswire
17 Aug 2026, 12:45 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
AimwellBio has acquired the Trustr intellectual property portfolio, a patented behavioral engagement system previously piloted with Sanofi. — Acquiring patented, pharma-tested technology reduces R&D risk and provides a tangible asset for commercialization.
+0.60Dr. Chris A. Jones, the behavioral economist and inventor of the Trustr portfolio, has joined the AimwellBio Board of Advisors. — Bringing the original inventor and a recognized expert (Oxford/Bertarelli Prize) onto the board adds significant human capital and credibility.
+0.40The company is leveraging Dr. Jones's network to recruit additional scientists, physicians, and commercial operators to expand its advisory network. — Expanding the professional network increases the probability of securing future strategic partnerships and client contracts.
+0.30Which stocks this story touches
Continue reading
6 related stories
Search tags
The company acquired a patented behavioral AI portfolio and added a distinguished expert to its board of advisors.
Mentioned only in the context of a past pilot program, with no significant impact on current valuation.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Proactive Investors
26m ago
